A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey

被引:0
|
作者
Koseoglu, Mesrure [1 ]
Omerhoca, Sami [2 ]
Balci, Fatma Belgin [3 ]
Unal, Aysun [4 ]
Ozdemir, Zeynep [1 ]
Yuksel, Burcu [1 ]
Celik, Rabia Gokcen Gozubatik [1 ]
Toprak, Ufuk Emre [5 ]
Gursoy, Esra Azize [6 ]
Icen, Nilufer Kale [2 ]
Altunrende, Burcu [7 ]
机构
[1] Univ Hlth Sci, Bakirkoy Res & Training Hosp Neurol & Psychiat Di, Dept Neurol, Istanbul, Turkiye
[2] SBU Bagcilar Training & Res Hosp, Dept Neurol, Istanbul, Turkiye
[3] Haseki Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[4] Tekirdag Namik Kemal Univ, Dept Neurol, Fac Med, Tekirdag, Turkiye
[5] Istanbul Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
[6] Basaksehir Cam & Sakura City Hosp, Dept Neurol, Istanbul, Turkiye
[7] Taksim Educ & Res Hosp, Dept Neurol, Istanbul, Turkiye
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1598/1823
引用
收藏
页码:1017 / 1017
页数:1
相关论文
共 50 条
  • [21] REAL-WORLD PERSISTENCE ON CLADRIBINE TABLETS OF PATIENTS WITH RMS OVER 4 YEARS BASED ON CLAIMS DATA
    Giesl, N.
    Stahn, D.
    Osowski, U.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S505 - S506
  • [22] Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina
    Rojas, Juan Ignacio
    Alonso, Ricardo
    Luetic, Geraldine
    Patrucco, Liliana
    Casas, Magdalena
    Silva, Berenice
    Miguez, Jimena
    Deri, Norma
    Vrech, Carlos
    Liwacki, Susana
    Piedrabuena, Raul
    Silva, Emanuel
    Tkachuk, Veronica
    Burgos, Marcos
    Tavolini, Dario
    Zanga, Gisela
    Pinheiro, Amelia Alvez
    Hryb, Javier
    Leguizamon, Felisa
    Knorre, Eduardo
    Lopez, Pablo A.
    Martinez, Alejandra
    Carra, Adriana
    Serena, Marina Alonso
    Cristiano, Edgardo
    Correale, Jorge
    Garcea, Orlando
    Liguori, Nora Fernandez
    Contentti, Edgar Carnero
    [J]. CLINICAL NEUROPHARMACOLOGY, 2024, 47 (04) : 120 - 127
  • [23] A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
    Bose, Gauruv
    Rush, Carolina
    Atkins, Harold L.
    Freedman, Mark S.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [24] Predictors of cladribine effectiveness in multiple sclerosis: a real-world, multicenter, two-year follow-up study
    Petracca, M.
    Ruggieri, S.
    Barbuti, E.
    Ianniello, A.
    Fantozzi, R.
    Di Lemme, S.
    Maniscalco, G.
    Landi, D.
    Marfia, G.
    Di Gregorio, M.
    Iodice, R.
    Sinisi, L.
    Missione, R.
    Coppola, C.
    Bonavita, S.
    Borriello, G.
    Lus, G.
    Pozzilli, C.
    Signoriello, E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 787 - 787
  • [25] Real-World Experience in an Irish Centre using Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis
    O'Donnell, Martin
    Pavalaghanthan, Hariesh
    Jose, Shinto
    Mitten, Ethna
    Ryan, Aisling
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1000 - 1001
  • [26] Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
    Oreja-Guevara, Celia
    Brownlee, Wallace
    Celius, Elisabeth G.
    Centonze, Diego
    Giovannoni, Gavin
    Hodgkinson, Suzanne
    Kleinschnitz, Christoph
    Kubala Havrdova, Eva
    Magyari, Melinda
    Selchen, Daniel
    Vermersch, Patrick
    Wiendl, Heinz
    Van Wijmeersch, Bart
    Salloukh, Hashem
    Yamout, Bassem
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [27] Real-World Evidence With Five-Year Data (2017-2022) on the use of Cladribine Tablets in Patients With Multiple Sclerosis in England: An Updated Analysis From the CLARENCE Study
    Brownlee, Wallace
    Amin, Amerah
    Ashton, Luke
    Herbert, Alex
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 993 - 994
  • [28] Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)
    Patti, Francesco
    Visconti, Andrea
    Capacchione, Antonio
    Roy, Sanjeev
    Trojano, Maria
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [29] REAL WORLD DATA EVALUATING EFFICACY AND SAFETY OF ORAL CLADRIBINE FOR MULTIPLE SCLEROSIS
    Nasir, Moneeb
    Rabvukwa, Plaxedes
    Fuller, Sarah
    Chaudhuri, Abhijit
    Mattoscio, Miriam
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [30] Cladribine as treatment of multiple sclerosis, real world experience
    Celius, E. G.
    Berg-Hansen, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 527 - 528